MongoDB, Inc. Announces Date of Third Quarter Fiscal 2021 Earnings Call

PR Newswire

NEW YORK, Nov. 18, 2020 /PRNewswire/ — MongoDB, Inc. (NASDAQ: MDB), the leading modern, general purpose database platform, today announced it will report its third quarter fiscal year 2021 financial results for the three months ended October 31, 2020, after the U.S. financial markets close on Tuesday, December 8, 2020.

In conjunction with this announcement, MongoDB will host a conference call on Tuesday, December 8, 2020, at 5:00 p.m. (Eastern Time) to discuss the Company’s financial results and business outlook. A live webcast of the call will be available on the “Investor Relations” page of the Company’s website at http://investors.mongodb.com. To access the call by phone, dial 844-808-6880 (domestic) or 412-317-5284 (international). A replay of this conference call will be available for a limited time at 877-344-7529 (domestic) or 412-317-0088 (international) using conference ID 10150178. A replay of the webcast will also be available for a limited time at http://investors.mongodb.com.

About MongoDB

MongoDB is the leading modern, general purpose database platform, designed to unleash the power of software and data for developers and the applications they build. Headquartered in New York, MongoDB has more than 20,200 customers in over 100 countries. The MongoDB database platform has been downloaded over 125 million times and there have been more than one million MongoDB University registrations.

Investor Relations

Brian Denyeau

ICR for MongoDB
646-277-1251
[email protected]

Media Relations

Ben Wolfson/Tom McMahon
MongoDB
[email protected]

 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/mongodb-inc-announces-date-of-third-quarter-fiscal-2021-earnings-call-301176424.html

SOURCE MongoDB, Inc.

Merchants Bancorp Declares Quarterly Common and Preferred Dividends

PR Newswire

CARMEL, Ind., Nov. 18, 2020  /PRNewswire/ — Merchants Bancorp (“Merchants”) (Nasdaq: MBIN), parent company and registered bank holding company of Merchants Bank of Indiana (“Merchants Bank”), today announced that its Board of Directors declared the following quarterly cash dividends for the fourth quarter of 2020, in each case to shareholders of record on December 15, 2020, payable on January 4, 2021:

  • A dividend of $0.08 per share on the Company’s outstanding shares of its common stock (NASDAQ:MBIN);
  • A dividend of $0.4375 per share on the Company’s outstanding shares of its 7% Series A preferred stock (NASDAQ:MBINP);
  • A dividend of $15.00 per share (equivalent to $0.375 per depositary share) on the Company’s outstanding shares of its 6% Series B preferred stock (NASDAQ:MBINO).

ABOUT MERCHANTS BANCORP
Merchants Bancorp is a diversified bank holding company headquartered in Carmel, Indiana operating multiple lines of business, including multi-family housing and healthcare facility financing and servicing, mortgage warehouse financing, retail and correspondent residential mortgage banking, agricultural lending and traditional community banking.  Merchants Bancorp, with $9.5 billion in assets and $7.1 billion in deposits as of September 30, 2020, conducts its business through its direct and indirect subsidiaries, Merchants Bank of Indiana, Merchants Capital Corp., Farmers-Merchants Bank of Illinois, and Merchants Mortgage, a division of Merchants Bank of Indiana. For more information and financial data, please visit Merchants’ Investor Relations page at investors.merchantsbancorp.com.

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/merchants-bancorp-declares-quarterly-common-and-preferred-dividends-301176420.html

SOURCE Merchants Bancorp

Universal Technical Institute Reports Fiscal Year 2020 Fourth Quarter and Year-End Results

PR Newswire

PHOENIX, Nov. 18, 2020 /PRNewswire/ — Universal Technical Institute, Inc. (NYSE: UTI), the leading provider of transportation technician training, reported financial results for the fiscal 2020 fourth quarter and full year ended September 30, 2020.

  • Fourth quarter net income was $6.5 million, up 17.8% from prior year period, while net income for the year was $8.0 million compared to a net loss in the prior year of $7.9 million.
  • Available liquidity of $114.9 million as of the end of the fourth quarter, an increase of $23 million versus the end of the prior quarter. Includes unrestricted cash, cash equivalents, and short-term held-to-maturity securities.
  • Started 5,772 new students in the fourth quarter, which increased 1.1% versus the prior year on a comparable basis1. Year over year start growth from August 31st through September 30th was 14.8%.
  • UTI expects double-digit growth in new student starts, revenue, adjusted EBITDA, net income, and adjusted free cash flow during fiscal year 2021.

“In fiscal 2020, UTI’s team demonstrated the very best of the human spirit as they guided the company, our students and industry partners through the most challenging environment imaginable,” said Jerome Grant, UTI’s Chief Executive Officer. “Through hard work and new and innovative approaches, including the introduction of our blended learning model, all 12 UTI campuses across eight states re-opened by the beginning of July and have remained fully operational ever since. Our business continues to gather momentum despite the challenging environment, and our focus, as always, remains on delivering strong outcomes for our students. This outcome-based student-centered approach lies at the heart of UTI’s unique value proposition and, for the past five decades, it has set us apart.

“I’m excited about the trends in our business and remain even more optimistic about the path forward as we look to accelerate our growth and diversify our business model, supported by our strong balance sheet. In the coming year, we will continue to demonstrate our ability to adapt to changes in the economic and political environment. At the same time, we expect to pursue organic and in-organic growth opportunities, allowing us to be flexible in terms of timing and capital allocation. We plan to share more about these opportunities and our work to strengthen and advance the UTI business model in the months ahead,” said Grant.

Financial Results for the Three-Month Period Ended September 30, 2020 Compared to 2019

  • New student starts increased 1.1% on a comparable basis1 but were down 10.3% when including the July 1, 2019 start date. Additionally, new student starts from the August 31, 2020 start date through the September 28, 2020 start date, increased 14.8% versus the comparable prior year period.
  • Revenues decreased 12.9% to $76.3 million, compared to $87.7 million, which includes the deferral of $6.1 million of revenue related to the timing of completion of student make-up labs, as well as overall lower average revenue per student driven by the pace in which students are progressing through their programs due to the impacts of COVID-19.
  • Operating expenses decreased 14.7% to $70.2 million, compared to $82.2 million. The decrease was primarily attributable to cost management initiatives resulting in lower headcount and related compensation and benefits expense, as well as lower occupancy, depreciation, travel and other expenses.
  • Operating income was $6.2 million, compared to an operating loss of $5.4 million.
  • Net income was $6.5 million, compared to $5.5 million. Basic and diluted earnings per share (EPS) were $0.10 and $0.09, respectively.
  • Adjusted operating income* was $6.3 million, compared to $5.8 million.
  • Adjusted EBITDA* was $9.7 million, compared to $10.4 million.

Financial Results for the Year Ended September 30, 2020 Compared to 2019

  • New student starts were down 2.4%, excluding the Norwood, MA campus. New student starts grew year over year in three of the four quarters during the fiscal year and have grown in eight of the last nine fiscal quarters.
  • Revenues decreased 9.3% to $300.8 million, compared to $331.5 million, which includes the deferral of $6.1 million of revenue related to the timing of completion of student make-up labs, as well as overall lower average revenue per student driven by the pace in which students are progressing through their programs and lower average students due to the impacts of COVID-19.
  • Operating expenses decreased 10.2% to $304.6 million, compared to $339.3 million, primarily as a result of cost management initiatives and the impacts of the COVID-19 pandemic. Additionally, fiscal 2020 included $1.5 million of severance cost related to the CEO transition, while fiscal 2019 included a $4.0 million consultant termination fee expense.
  • Operating loss was $3.9 million, compared to $7.8 million.
  • Net income was $8.0 million, compared to a net loss of $7.9 million, and includes a $10.7 million tax benefit resulting from the application of revised net operating loss carryback regulations from the CARES Act. Basic and diluted EPS were $0.05.
  • Adjusted operating income* was $0.9 million, compared to a loss of $1.7 million.
  • Adjusted EBITDA* was $14.0 million, compared to $17.0 million.
  • Cash flow provided by operating activities was $11.0 million, compared to $21.7 million.
  • Adjusted free cash flow* was $4.3 million, compared to $20.7 million.

*See “Use of Non-GAAP Financial Information” below.

“We exited fiscal 2020 with more active students than we had at the end of fiscal 2019, driven by the significant acceleration of new student starts throughout the fourth quarter as well as by students  who are continuing to progress through the curriculum and were delayed due to COVID,” said Troy Anderson, UTI’s Chief Financial Officer. “Approximately 1,900 students graduated during the fourth quarter, and as of the completion of the most recent course rotation, 78 percent of students are fully current with their hands-on labs, versus 40 percent at the time of our last earnings announcement, while the percentage of students exclusively participating online fell from 13 percent to 3 percent.

Student Metrics


Three Months Ended


Twelve Months Ended


September 30,


September 30,


2020


2019


2020


2019

Total starts

5,772

6,437(1)

11,283

11,652

Total starts (excluding Norwood, MA)

5,772

6,437(1)

11,283

11,562

Average undergraduate full-time student enrollment

11,251

10,933

10,462

10,674

End of period undergraduate full-time student enrollment

12,524

12,363

12,524

12,363

(1) Includes 725 starts on July 1, 2019.  The comparable view excludes this start as the similar start for fiscal 2020 occurred in the third quarter on June 29, 2020.

 

Fiscal 2021 Financial Outlook

“The growth acceleration we saw at the end of fiscal 2020 has so far continued into this fiscal year. We have seen double-digit growth in new student starts for the first quarter and in the number of students scheduled to start in the first and second quarters compared to the same time last year. We are also seeing measurable show rate improvement versus the comparable prior year pre-COVID period,” Anderson said. “These trends, along with continued progress on lab make-ups, heavy top-of-the-funnel demand, and ongoing cost efficiency opportunities give us confidence about our expected performance in fiscal 2021. Despite potential uncertainties with the COVID pandemic, we feel it is important to establish guidance for the fiscal year, where we expect to see growth across all of our key metrics including student starts, revenue, adjusted EBITDA*, and adjusted free cash flow*, and to deliver positive net income for the second consecutive year.” 


($ in millions)


FY 2020 Actuals


FY 2021 Guidance

New student start growth (decline)

(2.4)%(2)

10.0% – 15.0%

Revenue growth

(9.3)%

10.0% – 15.0%

Net income

$8.0

$14.0 – $19.0

Adjusted EBITDA

$14.0

$30.0 – $35.0

Adjusted free cash flow(3)

$4.3

$20.0 – $25.0

(2) Excludes Norwood, MA.

(3) Includes $9.3 million of capex for FY2020 and $15 to $20 million of capex for FY2021. The FY2021 capex assumes incremental investments for new welding programs launching during the fiscal year, online curriculum enhancements and campus optimization efforts, in addition to a consistent level of annual maintenance capex and certain projects deferred from FY2020.

 

Conference Call

Management will hold a conference call to discuss the financial results for the fiscal 2020 fourth quarter ended September 30, 2020, on Wednesday, November 18, 2020, at 1:30 p.m. PT (4:30 p.m. ET).

To participate in the live call, investors are invited to dial (844) 881-0138 (domestic) or (412) 317-6790 (international).  A live webcast of the call will be available via the Universal Technical Institute investor relations website at https://investor.uti.edu. Please go to the website at least 10 minutes early to register, download and install any necessary audio software. The conference call webcast will be archived for 90 days at https://investor.uti.edu or the telephone replay can be accessed through December 2, 2020, by dialing (877) 344-7529 (domestic) or (412) 317-0088 (international) and entering passcode 10149609.

Use of Non-GAAP Financial Information

In addition to disclosing financial results that are determined in accordance with U.S. generally accepted accounting principles (“GAAP”), UTI also discloses certain non-GAAP financial information in this press release and the related conference call. These financial measures are not recognized measures under GAAP and are not intended to be and should not be considered in isolation or as a substitute for, or superior to, the financial information prepared and presented in accordance with GAAP.  UTI discloses these non-GAAP financial measures because it believes that they provide investors an additional analytical tool to clarify its results of operations and identify underlying trends. Additionally, UTI believes that these measures may also help investors compare its performance on a consistent basis across time periods.


Adjusted EBITDA

UTI defines adjusted EBITDA as net income (loss) before interest expense, interest income, income taxes, depreciation, amortization and adjusted for items not considered as part of the company’s normal recurring operations.


Adjusted Operating Income (Loss)

UTI defines adjusted operating income (loss) as income (loss) from operations, adjusted for items that affect trends in underlying performance from year to year and are not considered normal recurring cash operating expenses.


Adjusted Free Cash Flow

UTI defines adjusted free cash flow as net cash provided by (used in) operating activities less capital expenditures, adjusted for items not considered as part of the company’s normal recurring operations.

UTI discloses any campus adjustments as direct costs (net of any corporate allocations). Management utilizes adjusted figures as performance measures internally for operating decisions, strategic planning, annual budgeting and forecasting.  For the periods presented, this includes consulting fees incurred as part of the company’s transformation initiative, severance expenses due to the CEO transition, startup costs related to the teach out and closure of the Norwood, MA campus. To obtain a complete understanding of UTI’s performance, these measures should be examined in connection with net income (loss), operating income (loss) and net cash provided by (used in) operating activities, determined in accordance with GAAP, as presented in the financial statements and notes thereto included in the annual and quarterly filings with the Securities and Exchange Commission (“SEC”).  Because the items excluded from these non-GAAP measures are significant components in understanding and assessing UTI’s financial performance under GAAP, these measures should not be considered to be an alternative to net income (loss), operating income (loss) or net cash provided by (used in) operating activities as a measure of UTI’s operating performance or liquidity.  Exclusion of items in the non-GAAP presentation should not be construed as an inference that these items are unusual, infrequent or non-recurring. Other companies, including other companies in the education industry, may define and calculate non-GAAP financial measures differently than UTI does, limiting their usefulness as a comparative measure across similarly titled performance measures presented by other companies. A reconciliation of the historical non-GAAP financial measures to the most directly comparable GAAP measures is provided below.

Forward Looking Statements

All statements contained in this press release and the related conference call, other than statements of historical fact, are “forward-looking” statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and Section 27A of the Securities Act of 1933, as amended. These forward-looking statements which address UTI’s expected future business and financial performance, may contain words such as “goal,” “target,” “future,” “estimate,” “expect,” “anticipate,” “intend,” “plan,” “believe,” “seek,” “project,” “may,” “should,” “will” or similar expressions. Examples of forward-looking statements include, among others, statements regarding (1) UTI’s belief that it is taking steps to address costs, efficiencies and working capital management; (2) UTI’s ability to maintain open campuses during the global pandemic and complete curriculum with in-person labs; (3) UTI’s belief that it is taking steps to drive its next phase of organic and inorganic growth; (4) UTI’s focus on offering a blended curriculum to provide students training for job skills that are in high demand; (5) UTI’s commitment to delivering the next phase of profitable growth and generating positive returns for all stakeholders; (6) UTI’s expectation for year-over-year annual growth; (7) UTI’s expectation for normal seasonality; (8) UTI’s focus on continuing to fuel long-term growth and investing in opening more welding programs that will drive incremental growth over the next two fiscal years; and (9) UTI’s expectations for new student start growth, average student population growth, revenue, operating expenses, operating income (loss), adjusted operating income (loss), net income, adjusted EBITDA, operating cash flow, adjusted free cash flow, and capital expenditures for fiscal 2021.  Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based only on UTI’s current beliefs, expectations and assumptions regarding the future of its business, future plans and strategies, projections, anticipated events and trends, the economy and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of UTI’s control. UTI’s actual results and financial condition may differ materially from those indicated in the forward-looking statements. Therefore, you should not rely on any of these forward-looking statements. Important factors that could affect UTI’s actual results include, among other things, impacts related to the COVID-19 pandemic, changes to federal and state educational funding, changes to regulations or agency interpretation of such regulations affecting the for-profit education industry, possible failure or inability to obtain regulatory consents and certifications for new or modified campuses or instruction, potential increased competition, changes in demand for the programs UTI offers, increased investment in management and capital resources, the effectiveness of UTI student recruiting, advertising and promotional efforts, changes to interest rates and unemployment, general economic and political conditions, the adoption of new accounting standards, and other risks that are described from time to time in UTI’s public filings. Further information on these and other potential factors that could affect the financial results or condition may be found in the company’s filings with the SEC.  Any forward-looking statements made by UTI in this press release and the related conference call are based only on information currently available to UTI and speak only as of the date on which it is made.  UTI expressly disclaims any obligation to publicly update any forward-looking statements, whether written or oral, that may be made from time to time, whether as a result of new information, future developments, changes in expectations, any changes in events, conditions or circumstances, or otherwise.

Social Media Disclosure

Universal Technical Institute (UTI) uses its website (https://www.uti.edu/) and LinkedIn page (https://www.linkedin.com/school/universal-technical-institute/) as channels of distribution of information about its programs, its planned financial and other announcements, its attendance at upcoming investor and industry conferences, and other matters. Such information may be deemed material information, and UTI may use these channels to comply with its disclosure obligations under Regulation FD. Therefore, investors should monitor the company’s website and its social media accounts in addition to following the company’s press releases, SEC filings, public conference calls, and webcasts.

About Universal Technical Institute, Inc.

With more than 220,000 graduates in its 55-year history, Universal Technical Institute, Inc. (NYSE: UTI) is the nation’s leading provider of technical training for automotive, diesel, collision repair, motorcycle and marine technicians, and offers welding technology and computer numerical control (CNC) machining programs. The company has built partnerships with industry leaders, outfits its state-of-the-industry facilities with current technology, and delivers training that is aligned with employer needs. Through its network of 12 campuses nationwide, UTI offers post-secondary programs under the banner of several well-known brands, including Universal Technical Institute (UTI), Motorcycle Mechanics Institute and Marine Mechanics Institute (MMI) and NASCAR Technical Institute (NASCAR Tech). The company is headquartered in Phoenix, Arizona.

For more information, visit www.uti.edu. Like UTI on www.facebook.com/UTI or follow UTI on Twitter @UTITweet, @MMITweet, and @NASCARTechUTI.

Company Contact:

Troy R. Anderson

Chief Financial Officer
Universal Technical Institute, Inc.
(623) 445-9365

Investor Relations Contact:

Robert Winters or Wyatt Turk
Alpha IR Group
(312) 445-2870
[email protected]

(Tables Follow)

 


UNIVERSAL TECHNICAL INSTITUTE, INC. AND SUBSIDIARIES


CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(In thousands, except per share amounts)

(Unaudited)


Three Months Ended


Twelve Months Ended


September 30,


September 30,


2020


2019


2020


2019

Revenues

$

76,327

$

87,666

$

300,761

$

331,504

Operating expenses:

Educational services and facilities

37,671

43,924

155,932

178,317

Selling, general and administrative

32,503

38,304

148,700

160,989

Total operating expenses

70,174

82,228

304,632

339,306

Income (loss) from operations

6,153

5,438

(3,871)

(7,802)

Other income (expense):

Interest income

251

338

1,152

1,491

Interest expense

(5)

(796)

(10)

(3,220)

Equity in earnings of unconsolidated affiliate

101

399

Other income

148

346

135

1,467

Total other income (expense), net

394

(11)

1,277

137

Income (loss) before income taxes

6,547

5,427

(2,594)

(7,665)

Income tax (expense) benefit

(97)

50

10,602

(203)

Net income (loss)

$

6,450

$

5,477

$

8,008

$

(7,868)

Preferred stock dividends

1,323

1,323

5,264

5,250

Income (loss) available for distribution

$

5,127

$

4,154

$

2,744

$

(13,118)

Earnings per share:

Net income (loss) per share – basic

$

0.10

$

0.09

$

0.05

$

(0.52)

Net income (loss) per share – diluted

$

0.09

$

0.09

$

0.05

$

(0.52)

Weighted average number of shares outstanding:

Basic

32,616

25,523

29,812

25,438

Diluted

32,973

26,106

30,113

25,438

 

 


UNIVERSAL TECHNICAL INSTITUTE, INC. AND SUBSIDIARIES


CONDENSED CONSOLIDATED BALANCE SHEETS

(In thousands, except par value and per share amounts)

(Unaudited)


September 30, 2020


September 30, 2019


Assets

Cash and cash equivalents

$

76,803

$

65,442

Restricted cash

12,116

15,113

Held-to-maturity investments

38,055

Receivables, net

35,411

17,937

Notes receivable, current portion

5,184

5,227

Prepaid expenses

6,121

7,054

Other current assets

6,489

7,331

Total current assets

180,179

118,104

Property and equipment, net

72,743

104,126

Goodwill

8,222

8,222

Right-of-use assets for operating leases

144,663

Notes receivable, less current portion

27,609

29,852

Other assets

8,565

10,222

Total assets

$

441,981

$

270,526


Liabilities and Shareholders’ Equity

Accounts payable and accrued expenses

$

51,891

$

45,878

Deferred revenue

40,694

42,886

Accrued tool sets

3,148

2,586

Operating lease liability, current portion

23,666

Financing obligation, current portion

1,554

Other current liabilities

2,241

3,940

Total current liabilities

121,640

96,844

Operating lease liability

134,089

Deferred tax liabilities, net

674

329

Deferred rent liability

10,326

Financing obligation

39,161

Other liabilities

9,056

9,578

Total liabilities

265,459

156,238

Commitments and contingencies

Shareholders’ equity:

Common stock, $0.0001 par value, 100,000 shares authorized, 32,730 and 32,499 shares issued, and 32,647 and 25,634 shares outstanding as of September 30, 2020 and 2019, respectively

3

3

Preferred stock, $0.0001 par value, 10,000 shares authorized; 700 shares of Series A Convertible Preferred Stock issued and outstanding as of September 30, 2020 and 2019, liquidation preference of $100 per share

Paid-in capital – common

141,002

187,493

Paid-in capital – preferred

68,853

68,853

Treasury stock, at cost, 82 and 6,865 shares as of September 30, 2020 and 2019, respectively

(365)

(97,388)

Retained deficit

(32,971)

(44,673)

Total shareholders’ equity

176,522

114,288

Total liabilities and shareholders’ equity

$

441,981

$

270,526

 

 


UNIVERSAL TECHNICAL INSTITUTE, INC. AND SUBSIDIARIES


CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(In thousands) (Unaudited)


Twelve Months Ended Sept. 30,


2020


2019


Cash flows from operating activities:

Net income (loss)

$

8,008

$

(7,868)

Adjustments to reconcile net income (loss) to net cash provided by operating activities:

Depreciation and amortization

11,804

13,222

Amortization of assets subject to financing obligation

2,682

Amortization of right-of-use assets for operating leases

24,273

Bad debt expense

1,767

1,166

Stock-based compensation

2,077

1,390

Deferred income taxes

345

Equity in earnings of unconsolidated affiliate

(399)

Training equipment credits earned, net

541

302

Other (gains) losses, net

(52)

561

Changes in assets and liabilities:

Receivables

(13,749)

(1,483)

Notes receivable

2,286

1,298

Prepaid expenses and other current assets

(1,016)

3,157

Other assets

(76)

1,016

Accounts payable and accrued expenses

7,020

2,942

Deferred revenue

(2,192)

4,650

Income tax (receivable) payable

(6,989)

166

Accrued tool sets and other current liabilities

1,863

300

Deferred rent liability

(1,677)

Operating lease liability

(25,617)

Other liabilities

739

321

Net cash provided by operating activities

11,032

21,746


Cash flows from investing activities:

Purchase of property and equipment

(9,262)

(6,453)

Proceeds from disposal of property and equipment

64

34

Purchase of held-to-maturity investments

(69,678)

Proceeds received upon maturity of investments

31,289

Proceeds from life insurance policy

1,566

Return of capital contribution from unconsolidated affiliate

261

267

Net cash used in investing activities

(45,760)

(6,152)


Cash flows from financing activities:

Proceeds from equity offering

49,153

Payment of preferred stock cash dividend

(5,264)

(5,250)

Payment of financing obligation and finance leases

(99)

(1,319)

Payment of payroll taxes on stock-based compensation through shares withheld

(698)

(629)

Net cash provided by (used in) financing activities

43,092

(7,198)

Change in cash, cash equivalents and restricted cash

8,364

8,396

Cash and cash equivalents, beginning of period

65,442

58,104

Restricted cash, beginning of period

15,113

14,055

Cash, cash equivalents and restricted cash, beginning of period

80,555

72,159

Cash and cash equivalents, end of period

76,803

65,442

Restricted cash, end of period

12,116

15,113

Cash, cash equivalents and restricted cash, end of period

$

88,919

$

80,555

 

 


UNIVERSAL TECHNICAL INSTITUTE, INC. AND SUBSIDIARIES


RECONCILIATION OF GAAP FINANCIAL INFORMATION TO NON-GAAP FINANCIAL INFORMATION

(In thousands)

(Unaudited)


Reconciliation of Net Income (Loss) to EBITDA


Three Months Ended


Twelve Months Ended


September 30,


September 30,


2020


2019


2020


2019

Net income (loss), as reported

$

6,450

$

5,477

$

8,008

$

(7,868)

Interest (income) expense, net

(246)

458

(1,142)

1,729

Income tax expense (benefit)

97

(50)

(10,602)

203

Depreciation and amortization

3,319

4,268

13,150

17,291

EBITDA

$

9,620

$

10,153

$

9,414

$

11,355

Non-recurring consulting fees for transformation initiative

4,224

Severance expense due to CEO transition

1,531

Net restructuring charge for Norwood, MA campus exit

48

1,433

Norwood, MA campus EBITDA

66

154

3,005

(51)

Adjusted EBITDA, non-GAAP

$

9,686

$

10,355

$

13,950

$

16,961

 


Reconciliation of Net Cash Provided by (Used in) Operating Activities to Adjusted Free Cash Flow


Twelve Months Ended Sept. 30,


2020


2019

Net cash provided by operating activities, as reported

$

11,032

$

21,746

Purchase of property and equipment

(9,262)

(6,453)

Severance payment due to CEO transition

1,218

Non-recurring consulting fees for transformation initiative

3,950

Cash outflow associated with Norwood, MA campus exit

1,362

Cash outflow associated with Norwood, MA campus operating activities

1,302

104

Adjusted free cash flow, non-GAAP

$

4,290

$

20,709

 


Reconciliation of Income (Loss) from Operations to Adjusted Operating Income (Loss)


Three Months Ended


Twelve Months Ended


September 30,


September 30,


2020


2019


2020


2019

Income (loss) from operations, as reported

$

6,153

$

5,438

$

(3,871)

$

(7,802)

Non-recurring consulting fees for transformation initiative

4,224

Severance expense due to CEO transition

1,531

Net restructuring charge for Norwood, MA campus exit

48

1,433

Norwood, MA campus operating loss

103

266

3,272

419

Adjusted operating income (loss), non-GAAP

$

6,256

$

5,752

$

932

$

(1,726)

 

 


UNIVERSAL TECHNICAL INSTITUTE, INC. AND SUBSIDIARIES


SELECTED SUPPLEMENTAL INFORMATION

(In thousands)

(Unaudited)


Selected Supplemental Financial Information


Three Months Ended


Twelve Months Ended


September 30,


September 30,


2020


2019


2020


2019

Salaries expense

$

31,997

$

32,877

$

128,782

$

136,022

Employee benefits and tax

5,289

6,889

23,450

30,102

Bonus expense

(159)

3,957

12,139

11,268

Stock-based compensation

517

(91)

2,077

1,440

Total compensation and related costs

$

37,644

$

43,632

$

166,448

$

178,832

Advertising expense

$

9,645

$

9,748

$

39,707

$

41,163

Occupancy expense, net of subleases

$

9,419

$

9,550

$

39,783

$

36,759

Depreciation and amortization expense

$

3,319

$

4.268

$

13,150

$

17,291

Contract service expense

$

1,815

$

1,761

$

7,108

$

11,902

 


Graduate Employment Rate


Twelve Months Ended Sept. 30,


2019


2018

Graduate employment rate

84

%

86

%

Graduates

8,482

8,117

Graduates available for employment

8,065

7,709

Graduates employed

6,763

6,664

The employment calculation is based on all graduates, including those that completed manufacturer specific advanced training programs, from October 1, 2018, to September 30, 2019, and October 1, 2017, to September 30, 2018, respectively, excluding graduates not available for employment because of continuing education, military service, health, incarceration, death or international student status.

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/universal-technical-institute-reports-fiscal-year-2020-fourth-quarter-and-year-end-results-301176280.html

SOURCE Universal Technical Institute, Inc.

Hemisphere Media Group Announces New $20 Million Share Repurchase Plan

PR Newswire

MIAMI, Nov. 18, 2020 /PRNewswire/ — Hemisphere Media Group, Inc. (NASDAQ:HMTV) (“Hemisphere” or the “Company”), announced today that its Board of Directors has authorized the Company to repurchase its Class A common stock for an aggregate purchase price of up to $20 million. This stock repurchase program is designed to return value to Hemisphere stockholders, and the Company anticipates utilizing this repurchase program opportunistically from time to time as deemed appropriate.

“Today’s share repurchase plan announcement demonstrates the Board and management’s confidence in our long-term prospects and growth opportunities, supported by a rebounding advertising market and our continued strong performance,” said Alan Sokol, Chief Executive Officer of Hemisphere. “We have clearly proven our ability to execute, particularly during these challenging times, and have demonstrated opportunistic capital allocation and robust free cash flow generation.  We are pleased that the Company’s well-capitalized balance sheet provides us the potential to continue returning value to our shareholders over the long-term.”

The new repurchase program may be implemented through open market repurchases or privately negotiated transactions, at management’s discretion, as permitted by securities laws and other legal and contractual requirements, and subject to market and business conditions and other factors. There is no guarantee as to the exact number of shares that will be repurchased under the plan.  The new stock repurchase program does not obligate Hemisphere to acquire any specific amount of common stock and the plan may be suspended or discontinued at any time in the Company’s sole discretion, subject to applicable securities laws.


Forward-Looking Statements

Statements in this press release and oral statements made from time to time by representatives of Hemisphere may contain certain statements about Hemisphere and its consolidated subsidiaries that are “forward-looking statements” within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. These include, but are not limited to, the deterioration of general economic conditions, political instability, social unrest, and public health crises, such as the occurrence of a global pandemic like the novel coronavirus, either nationally or in the local markets in which Hemisphere operates, Puerto Rico’s uncertain political climate, as well as delays in the disbursement of earmarked federal funds on the local economy and advertising market, the effects of Hurricane Maria and the earthquakes earlier this year in Puerto Rico on Hemisphere’s business and the advertising market in Puerto Rico as well as Hemisphere’s customers, employees, third-party vendors and suppliers, the effect on affiliate revenue that Hemisphere receives, short and long-term migration shifts in Puerto Rico, Hemisphere’s ability to timely and fully recover proceeds under our insurance policies Hemisphere’s ability to successfully integrate acquired assets and achieve anticipated synergies, statements relating to Hemisphere’s future financial and operating results (including growth and earnings), plans, objectives, expectations and intentions and other statements that are not historical facts. These statements are based on the current expectations of the management of Hemisphere and are subject to uncertainty and changes in circumstance, which may cause actual results to differ materially from those expressed or implied in such forward-looking statements. Without limitation, any statements preceded or followed by or that include the words “targets,” “plans,” “believes,” “expects,” “intends,” “will,” “likely,” “may,” “anticipates,” “estimates,” “projects,” “should,” “would,” “expect,” “positioned,” “strategy,” “future,” or words, phrases or terms of similar substance or the negative thereof, are forward-looking statements. In addition, these statements are based on a number of assumptions that are subject to change. Factors that could cause actual results to differ materially from those expressed or implied by the forward-looking statements are discussed under the headings “Risk Factors” and “Forward-Looking Statements” in Hemisphere’s most recent Annual Report on Form 10-K, filed with the Securities and Exchange Commission (“SEC”), as they may be updated in any future reports filed with the SEC. If one or more of these factors materialize, or if any underlying assumptions prove incorrect, Hemisphere’s actual results, performance, or achievements may vary materially from any future results, performance or achievements expressed or implied by these forward-looking statements. Forward-looking statements included herein are made as of the date hereof, and Hemisphere undertakes no obligation to update publicly such statements to reflect subsequent events or circumstances.


About Hemisphere Media Group, Inc.:

 Hemisphere Media Group, Inc. (HMTV) is the only publicly traded pure-play U.S. media company targeting the high-growth U.S. Hispanic and Latin American markets with leading television and digital content platforms. Headquartered in Miami, Florida, Hemisphere owns and operates five leading U.S. Hispanic cable networks, two Latin American cable networks, the leading broadcast television network in Puerto Rico, and has ownership interests in a leading broadcast television network in Colombia, a Spanish-language content distribution company, and Pantaya, a Spanish-language OTT service in the U.S.


Investor Relations Contact


Edelman Financial Communications for Hemisphere Media Group
Danielle O’Brien
917-444-6325
[email protected] 

Cision View original content:http://www.prnewswire.com/news-releases/hemisphere-media-group-announces-new-20-million-share-repurchase-plan-301176412.html

SOURCE Hemisphere Media Group, Inc.

MP Materials Announces Timing of Release of Financial Results and Earnings Conference Call

MP Materials Announces Timing of Release of Financial Results and Earnings Conference Call

MOUNTAIN PASS, Calif.–(BUSINESS WIRE)–
MP Materials Corp. (NYSE: MP) (“MP Materials”), the largest rare earth materials producer in the Western Hemisphere, today announced that it will release financial results for the period ended September 30, 2020, and host its first earnings conference call.

MP Materials expects to file a Form 8-K with the SEC after market close on Monday, November 23, 2020, containing its year-to-date financial results. In conjunction with the 8-K filing, the company will also issue a press release summarizing its third quarter 2020 results.

MP Materials will host a conference call and webcast on Tuesday, November 24, 2020, at 8:30 A.M. Eastern Time, with an accompanying slide presentation, to discuss the financial results. Interested parties can access the 8-K, press release and slide presentation on the investor relations portion of the company website at investors.mpmaterials.com.

Conference Call Details:

Event: MP Materials September 30, 2020, Financial Results Conference Call and Webcast

Date: Tuesday, November 24, 2020

Time: 8:30 A.M. Eastern Time

Live call: (833) 350-1335

International: (236) 389-2432

Audio Replay: (800) 585-8367

Passcode: 5090136

Webcast: investors.mpmaterials.com

The audio replay will be archived through December 8, 2020.

About MP Materials

MP Materials Corp. (NYSE: MP) is the largest producer of rare earth materials in the Western Hemisphere. With over 270 employees, the Company owns and operates Mountain Pass, an iconic American industrial asset, which is the only rare earth mining and processing site of scale in the Western Hemisphere and currently produces approximately 15% of global rare earth content. Separated rare earth elements are critical inputs for the magnets that enable the mobility of electric vehicles, drones, defense systems, wind turbines, robotics and many other high-growth, advanced technologies. MP Materials’ integrated operations at Mountain Pass uniquely combine low production costs with best-in-class environmental standards, thereby restoring American leadership to a critical industry with a strong commitment to sustainability. More information is available at https://mpmaterials.com/.

Investors:

Ellipsis

Jeff Majtyka

[email protected]

Media:

Edelman

Jordan Fisher

[email protected]

KEYWORDS: California United States North America

INDUSTRY KEYWORDS: Natural Resources Other Natural Resources Mining/Minerals

MEDIA:

Logo
Logo

Supermicro Announces Participation in Upcoming Investor Events

Supermicro Announces Participation in Upcoming Investor Events

SAN JOSE, Calif.–(BUSINESS WIRE)–Super Micro Computer, Inc. (SMCI), a global leader in high-performance, high-efficiency server and storage technology and green computing, announces that Kevin S. Bauer, Senior Vice President, Chief Financial Officer, and Patrick Wang, Senior Vice President, Strategy and Corporate Development, will participate in meetings with institutional investors at the following upcoming virtual events:

Event:

Non-Deal Roadshow, hosted by Susquehanna International Group

Dates:

November 23-24 and November 30, 2020

 

 

Event:

Wells Fargo TMT Summit 2020

Date:

December 1, 2020

 

 

Event:

Credit Suisse 24th Annual Technology Conference

Date:

December 2, 2020

About Super Micro Computer, Inc.

Supermicro (SMCI), the leading innovator in high-performance, high-efficiency server and storage technology, is a premier provider of advanced server Building Block Solutions® for Enterprise Data Center, Cloud Computing, Artificial Intelligence, and Edge Computing Systems worldwide. Supermicro is committed to protecting the environment through its “We Keep IT Green®” initiative and provides customers with the most energy-efficient, environmentally-friendly solutions available on the market.

Supermicro, Building Block Solutions and We Keep IT Green are trademarks and/or registered trademarks of Super Micro Computer, Inc.

SMCI-F

Investor Relations Contact:

James Kisner

Vice President, Investor Relations

(669) 284-1259

email: [email protected]

KEYWORDS: United States North America California

INDUSTRY KEYWORDS: Environment Technology Semiconductor Other Technology Software Networks Internet Hardware Data Management

MEDIA:

Logo
Logo

Spruce Biosciences Reports Third Quarter 2020 Financial Results and Provides Corporate Update

Spruce Biosciences Reports Third Quarter 2020 Financial Results and Provides Corporate Update

Successful Initiation of Late-Stage CAHmelia Program in Adult Classic CAH

FDA and EMA Scientific Advice Support Plans in Pediatric Classic CAH Program

IPO Results in Pro Forma Cash and Cash Equivalents of $168.4 Million

SAN FRANCISCO–(BUSINESS WIRE)–Spruce Biosciences, Inc. (Nasdaq: SPRB), a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with significant unmet medical need, today reported financial results for the third quarter ended September 30, 2020, and provided a corporate update.

Recent Accomplishments and Progress Toward Milestones

  • Successful Initiation of the Late-Stage CAHmelia Program in Adult Classic Congenital Adrenal Hyperplasia (CAH). CAHmelia-203 will assess the impact of tildacerfont, a CRF-1 receptor antagonist, on biomarker control and reducing clinical effects of disease in adult classic CAH patients with poor disease control. CAHmelia-204 will assess the effect of tildacerfont on glucocorticoid reduction and the clinical impact of that reduction in adult classic CAH patients with good disease control. Spruce believes that its two-study strategy may allow it to observe more clinically meaningful outcomes with fewer total patients studied. Screening activities are underway and substantial patient interest for participation in both studies has been registered at CAHstudy.com.

  • Pediatric Scientific Advice Meetings with FDA and European Medicines Agency (EMA) Completed. Spruce completed a scientific advice meeting with the EMA regarding its clinical development program of tildacerfont in children with classic CAH between the ages 2 and 17. Spruce plans to submit a Pediatric Investigational Plan (PIP) to the Pediatric Committee of the EMA regarding a Phase 3 registrational program in pediatrics. Scientific advice received from both the EMA and FDA also support Spruce’s plans to initiate its planned Phase 2 pediatric clinical trial in the second half of 2021.

  • Successful Completion of Initial Public Offering (IPO). Spruce closed its IPO in October 2020, resulting in net proceeds of $96.3 million, after deducting underwriting discounts and commissions of approximately $7.2 million and before deducting offering related expenses. When including net proceeds from the IPO, pro forma cash and cash equivalents as of September 30, 2020 were $168.4 million.

“The third quarter has been a transformational period for the company, marked by significant accomplishments. We have successfully initiated CAHmelia-203 and CAHmelia-204, our global late-stage development program in adult classic CAH, despite the challenges resulting from the COVID-19 pandemic,” said Richard King, Chief Executive Officer. “With the successful completion of our IPO in October 2020, our strong cash position enables us to fund our CAHmelia program through completion and into applications for approval from regulatory authorities, assuming positive study outcomes. In addition, tildacerfont continues to progress towards evaluation in additional indications, including pediatric classic CAH and a rare form of polycystic ovary syndrome driven by a hyper-responsiveness to elevated levels of adrenocorticotropic hormone. We are focused on executing our clinical development plans and look forward to providing more updates in the future.”

Financial Highlights

Cash and Cash Equivalents: Cash and cash equivalents as of September 30, 2020, were $72.2 million.

Research and Development (R&D) Expenses: R&D expenses consist primarily of pre-clinical, clinical and manufacturing expenses related to the development of tildacerfont. R&D expenses for the three and nine months ended September 30, 2020, were $7.8 million and $18.0 million compared to $2.1 million and $8.0 million for the same periods in 2019, respectively. The overall increase in R&D expenses was primarily related to an increase in clinical development, manufacturing, and personnel costs associated with advancement of tildacerfont into late-stage clinical development.

General and Administrative (G&A) Expenses: G&A expenses consist primarily of personnel costs, legal and other professional fees, insurance, and other administrative costs. G&A expenses for the three and nine months ended September 30, 2020, were $1.8 million and $3.0 million, compared to $0.5 million and $2.0 million for the same periods in 2019, respectively. The overall increase in G&A expenses was primarily driven by an increase in professional fees related to the IPO.

Net Loss: Net loss for the three and nine months ended September 30, 2020, was $9.6 million and $21.2 million, compared to $2.6 million and $9.9 million for the same periods in 2019, respectively.

About Spruce Biosciences

Spruce Biosciences is a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with significant unmet need. Spruce is initially developing its wholly-owned product candidate, tildacerfont, as the potential first non-steroidal therapy to offer markedly improved disease control and reduce steroid burden for patients suffering from classic congenital adrenal hyperplasia (CAH). Classic CAH is a serious and life-threatening disease with no known novel therapies approved in approximately 50 years.

Forward-Looking Statements

Statements contained in this press release regarding matters that are not historical facts are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements include statements regarding, among other things, the results, conduct, progress and timing of Spruce’s clinical trials, the regulatory approval path for tildacerfont, the strength of Spruce’s balance sheet and the adequacy of Spruce’s cash position. Because such statements are subject to risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking statements. Words such as “plans,” “will”, “potential” and similar expressions are intended to identify forward-looking statements. These forward-looking statements are based upon Spruce’s current expectations and involve assumptions that may never materialize or may prove to be incorrect. Actual results could differ materially from those anticipated in such forward-looking statements as a result of various risks and uncertainties, which include, without limitation, risks and uncertainties associated with Spruce’s business in general, the impact of the COVID-19 pandemic, and the other risks described in Spruce’s filings with the U.S. Securities and Exchange Commission. All forward-looking statements contained in this press release speak only as of the date on which they were made and are based on management’s assumptions and estimates as of such date. Spruce undertakes no obligation to update such statements to reflect events that occur or circumstances that exist after the date on which they were made, except as required by law.

Use of Non-GAAP Financial Measure

To supplement our financial information, which is prepared and presented in accordance with generally accepted accounting principles in the United States of America (“GAAP”), we use the following non-GAAP financial measure: pro forma cash and cash equivalents, which include the net proceeds from the IPO, after deducting underwriting discounts and commissions and before deducting offering related expenses. Management believes the non-GAAP financial measure is helpful to investors to evaluate the company’s financial position. The non-GAAP financial measure should be considered in addition to results prepared in accordance with GAAP but should not be considered a substitute for or superior to GAAP results.

There are a number of limitations related to the use of non-GAAP financial measures. In light of these limitations, we provide specific information regarding the GAAP amounts included or excluded from these non-GAAP financial measures and evaluating these non-GAAP financial measures together with their relevant financial measures in accordance with GAAP.

For more information on these non-GAAP financial measures, please see the section titled “Reconciliation of Non-GAAP Measure” included at the end of this release.

SPRUCE BIOSCIENCES, INC.

CONDENSED BALANCE SHEETS

(unaudited)

(in thousands, except share amounts)

 

 

 

September 30,

2020

 

 

December 31,

2019

 

ASSETS

 

 

 

 

 

 

 

 

Current assets:

 

 

 

 

 

 

 

 

Cash and cash equivalents

 

$

72,158

 

 

$

3,924

 

Prepaid expenses

 

 

1,233

 

 

 

215

 

Other current assets

 

 

209

 

 

 

513

 

Total current assets

 

 

73,600

 

 

 

4,652

 

Restricted cash

 

 

216

 

 

 

 

Right-of-use assets

 

 

1,869

 

 

 

 

Deferred offering costs

 

 

2,347

 

 

 

 

Other assets

 

 

453

 

 

 

40

 

Total assets

 

$

78,485

 

 

$

4,692

 

LIABILITIES, REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS’ EQUITY (DEFICIT)

 

 

 

 

 

 

 

 

Current liabilities:

 

 

 

 

 

 

 

 

Accounts payable

 

$

4,002

 

 

$

1,878

 

Term loan, current portion

 

 

1,908

 

 

 

1,252

 

Accrued expenses and other current liabilities

 

 

3,469

 

 

 

265

 

Accrued compensation and benefits

 

 

707

 

 

 

908

 

Total current liabilities

 

 

10,086

 

 

 

4,303

 

Term loan, net of current portion

 

 

2,561

 

 

 

3,193

 

Lease liability, net of current portion

 

 

1,738

 

 

 

 

Other liabilities

 

 

95

 

 

 

20

 

Total liabilities

 

 

14,480

 

 

 

7,516

 

 

 

 

 

 

 

 

 

 

Series A redeemable convertible preferred stock, $0.0001 par value, 28,000,000 shares authorized, issued, and outstanding as of September 30, 2020 and December 31, 2019; liquidation preference of $28,000 as of September 30, 2020 and December 31, 2019

 

 

27,813

 

 

 

27,813

 

Series B redeemable convertible preferred stock, $0.0001 par value, 73,333,330 shares authorized, issued, and outstanding as of September 30, 2020 and 0 shares authorized, issued and outstanding as of December 31, 2019; liquidation value of $88,000 as of September 30, 2020 and $0 as of December 31, 2019

 

 

87,633

 

 

 

 

Stockholders’ equity (deficit):

 

 

 

 

 

 

 

 

Common stock, $0.0001 par value, 130,518,922 and 41,000,000 shares authorized as of September 30, 2020 and December 31, 2019, respectively; 822,022 and 764,408 shares issued and outstanding as of September 30, 2020 and December 31, 2019, respectively

 

 

1

 

 

 

1

 

Additional paid-in capital

 

 

1,061

 

 

 

664

 

Accumulated deficit

 

 

(52,503

)

 

 

(31,302

)

Total stockholders’ equity (deficit)

 

 

(51,441

)

 

 

(30,637

)

Total liabilities, redeemable convertible preferred stock and stockholders’ equity (deficit)

 

$

78,485

 

 

$

4,692

 

 

SPRUCE BIOSCIENCES, INC.

CONDENSED STATEMENTS OF OPERATIONS

(unaudited)

(in thousands, except share and per share amounts)

 

 

 

Three Months Ended

September 30,

 

 

Nine Months Ended

September 30,

 

 

 

2020

 

 

2019

 

 

2020

 

 

2019

 

Operating expenses:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Research and development

 

$

7,769

 

 

$

2,107

 

 

$

18,040

 

 

$

7,969

 

General and administrative

 

 

1,790

 

 

 

457

 

 

 

3,041

 

 

 

2,004

 

Total operating expenses

 

 

9,559

 

 

 

2,564

 

 

 

21,081

 

 

 

9,973

 

Loss from operations

 

 

(9,559

)

 

 

(2,564

)

 

 

(21,081

)

 

 

(9,973

)

Interest expense

 

 

(79

)

 

 

(5

)

 

 

(245

)

 

 

(5

)

Other income, net

 

 

51

 

 

 

18

 

 

 

125

 

 

 

72

 

Net loss

 

$

(9,587

)

 

$

(2,551

)

 

$

(21,201

)

 

$

(9,906

)

Net loss per share, basic and diluted

 

$

(12.35

)

 

$

(3.34

)

 

$

(27.54

)

 

$

(12.96

)

Weighted-average shares of common stock outstanding, basic and diluted

 

 

776,159

 

 

 

764,408

 

 

 

769,766

 

 

 

764,408

 

 

SPRUCE BIOSCIENCES, INC.

RECONCILIATION OF NON-GAAP MEASURE

(unaudited)

(in thousands)

 

 

September 30,

2020

Cash and cash equivalents

 

$

72,158

Adjustments:

 

 

 

Net IPO proceeds after deducting underwriting discounts and commissions and before deducting offering related expenses

 

 

96,255

Pro forma cash and cash equivalents

 

$

168,413

 

Media

Will Zasadny

Canale Communications

(619) 961-8848

[email protected]

[email protected]

Investors

Thomas Hoffmann

Solebury Trout

(646) 378-2931

[email protected]

[email protected]

KEYWORDS: California United States North America

INDUSTRY KEYWORDS: Science Other Science Biotechnology Research Pharmaceutical General Health Health Other Health

MEDIA:

Logo
Logo

Domo to Present at the Credit Suisse 24th Annual Technology Conference

Domo to Present at the Credit Suisse 24th Annual Technology Conference

SILICON SLOPES, Utah–(BUSINESS WIRE)–Domo (Nasdaq: DOMO), provider of the Domo Business Cloud, today announced management will present at the Credit Suisse 24th Annual Technology Conference. The presentation is scheduled for November 30, 2020 at 1:40pm ET.

A live webcast of the conference presentation will be available on the Domo Investor Relations website at http://www.domo.com/IR.

About Domo

Domo is the Business Cloud, empowering organizations of all sizes with BI leverage at cloud scale, in record time. With Domo, BI-critical processes that took weeks, months or more can now be done on-the-fly, in minutes or seconds, at unbelievable scale. For more information about how Domo (Nasdaq: DOMO) helps its customers go fast, go big and go bold, visit www.domo.com. You can also follow Domo on Twitter, Facebook and LinkedIn.

Domo, Domo Business Cloud and Domo is the Business Cloud are registered trademarks of Domo, Inc.

Domo Disclosure Channels to Disseminate Information

Domo investors and others should note that we announce material information to the public about our company, products and services, and other issues through a variety of means, including Domo’s website, press releases, SEC filings, blogs and social media, in order to achieve broad, non-exclusionary distribution of information to the public. We intend to use the Domo Facebook page, the Domo LinkedIn page, the Domo blog, the @Domotalk Twitter account and the @JoshJames Twitter account as a means of disclosing information about the Company and its services and for complying with the disclosure obligations under Regulation FD. The information we post through these social media channels may be deemed material. Accordingly, we encourage investors and others to monitor these social media channels in addition to following our press releases, SEC filings and public conference calls and webcasts. The social media channels that we intend to use as a means of disclosing the information described here may be updated from time to time as listed on our investor relations webpage.

Media –

Julie Kehoe

[email protected]

Investors –

Peter Lowry

[email protected]

KEYWORDS: Utah United States North America

INDUSTRY KEYWORDS: Software Technology Data Management

MEDIA:

Logo
Logo

NRG Energy Recognizes Business Customers During Inaugural Excellence in Energy Awards

NRG Energy Recognizes Business Customers During Inaugural Excellence in Energy Awards

PRINCETON, N.J.–(BUSINESS WIRE)–
NRG Energy, Inc. (NSYE: NRG) honored its top energy customers in efficiency, sustainability and community through the inaugural Excellence in Energy Awards held on November 18, 2020.

The Excellence in Energy Awards identifies customers by industry that demonstrate a strong commitment to planning and implementation of sustainability and energy efficiency goals and are also engaged in the community. With the launch of these awards, NRG is applauding the energy achievements and milestones of its customers.

“Our customers inspire us every day at NRG,” said Robert Gaudette, Senior Vice President of NRG Energy, Inc. “This event is dedicated to them. We want to recognize our customers for their effort in optimizing their energy solutions and giving back to the community. The awards are about celebrating the ways organizations are taking charge of their energy future and moving toward more multi-faceted approaches benefiting them and their communities.”

NRG is honored to announce its first Excellence in Energy Award winners.

Sustainability

Each organization demonstrated a significant and measurable environmental impact.

  • Archdiocese of Galveston-Houston
  • Bank of America
  • City of Houston

Energy Efficiency

Organizations were recognized for achieving success with new technologies, solutions, and upgrades resulting in energy reduction or savings.

  • Dallas Independent School District
  • Houston Methodist Hospital

Community

Organizations were recognized for their achievements in community involvement.

  • Investment Corporation of America
  • YMCA Dallas Metropolitan

As a winner of the Excellence in Energy Awards, organizations further demonstrate and certify their excellence as an energy leader responsible with energy consumption and a good neighbor in the community.

Customers, brokers and account managers were invited to submit essay submissions outlining the achievements of the customers based on three categories: Community, Sustainability and Energy Efficiency. To be eligible, candidates needed to be a Reliant Energy or NRG Energy customer categorized as a large business with an active supply contract. Large business Sustainability and Energy Efficiency customers were also eligible.

Congratulations to all the organizations making advances on their energy journeys. NRG is already committed to recognizing excellence again in November 2021 for the next “Excellence in Energy” event.

About NRG

At NRG, we’re bringing the power of energy to people and organizations by putting customers at the center of everything we do. We generate electricity and provide energy solutions and natural gas to more than 3.7 million residential, small business, and commercial and industrial customers through our diverse portfolio of retail brands. A Fortune 500 company, operating in the United States and Canada, NRG delivers innovative solutions while advocating for competitive energy markets and customer choice, and by working towards a sustainable energy future.

Investors:

Kevin L. Cole, CFA

609.524.4526

[email protected]

Media:

Candice Adams

609.524.5428

[email protected]

KEYWORDS: New Jersey United States North America

INDUSTRY KEYWORDS: Other Energy Utilities Oil/Gas Coal Alternative Energy Energy Nuclear

MEDIA:

NYSE

Arca

Ticker

Registered

Issue Name

Declaration

Date

Ex-Date

Record

Date

Payment

Date

Coupon

Amount1

per Note

Current

Yield2

AMJ

Alerian MLP Index ETN

November 18, 2020

November 27, 2020

November 30, 2020

December 8, 2020

$0.3354

9.9%

The Notes are subject to a maximum issuance limitation of 129,000,000 Notes, which may cause the Notes to trade at a premium relative to the indicative note value. Investors that pay a premium for the Notes could incur significant losses if that investor sells its notes at a time when some or all of the premium is no longer present.

1) As defined in the Market-Making Supplement, dated April 8, 2020, for the Notes.

You may access this market making supplement as follows:

https://www.sec.gov/Archives/edgar/data/19617/000095010320007243/dp125818_424b2-aemsupp.htm

2) “Current Yield” equals the current Coupon Amount annualized and divided by the closing price of the Notes on November 17, 2020, and rounded to one decimal place for ease of analysis. The Current Yield is not indicative of future coupon payments, if any, on the Notes.

The Notes are senior, unsecured obligations of JPMorgan Chase & Co.

About JPMorgan Chase & Co.

JPMorgan Chase & Co. (NYSE: JPM) is a leading global financial services firm with assets of $3.2 trillion and operations worldwide. The Firm is a leader in investment banking, financial services for consumers and small businesses, commercial banking, financial transaction processing, and asset management. A component of the Dow Jones Industrial Average, JPMorgan Chase & Co. serves millions of customers in the United States and many of the world’s most prominent corporate, institutional and government clients under its J.P. Morgan and Chase brands. Information about JPMorgan Chase & Co. is available at www.jpmorganchase.com.

Investment suitability must be determined individually for each investor, and the Notes may not be suitable for all investors. This information is not intended to provide and should not be relied upon as providing accounting, legal, regulatory or tax advice.

Investors should consult with their own advisors as to these matters.

JPMorgan Chase & Co. has filed a registration statement (including a prospectus) with the Securities and Exchange Commission, or SEC, for the offering to which this communication relates.

Before you invest, you should read the prospectus in that registration statement and the other documents relating to this offering that JPMorgan Chase & Co. has filed with the SEC for more complete information about JPMorgan Chase & Co. and this offering.

You may get these documents without cost by visiting EDGAR on the SEC website at www.sec.gov. Alternatively, JPMorganChase & Co., any agent or any dealer participating in this offering will arrange to send you the prospectus, the prospectus supplement, the product supplement and the pricing supplement if you so request by calling toll-free 800-576-3529.

JPMorgan Alerian ETN team

1-800-576-3529

[email protected]

KEYWORDS: United States North America New York

INDUSTRY KEYWORDS: Banking Other Professional Services Professional Services Finance

MEDIA:

Logo
Logo